Trial Outcomes & Findings for Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation (NCT NCT02385292)

NCT ID: NCT02385292

Last Updated: 2021-10-19

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

23 participants

Primary outcome timeframe

Day 1

Results posted on

2021-10-19

Participant Flow

During transfer and acquisition of study record by sponsors, no study data has been located and all efforts to locate study data have been exhausted. Therefore, no study data is available to report at this time.

Participant milestones

Participant milestones
Measure
Intranasal Then Extranasal Application
Intranasal application of the Oculeve Intranasal Lacrimal Neurostimulator followed by extranasal application of the Oculeve Intranasal Lacrimal Neurostimulator.
Extranasal Then Intranasal Application
Extranasal application of the Oculeve Intranasal Lacrimal Neurostimulator followed by Intranasal application of the Oculeve Intranasal Lacrimal Neurostimulator.
Overall Study
STARTED
0
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: Day 1

Population: During transfer and acquisition of study record by sponsors, no study data has been located and all efforts to locate study data have been exhausted. Therefore, no study data is available to report at this time.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1

Population: During transfer and acquisition of study record by sponsors, no study data has been located and all efforts to locate study data have been exhausted. Therefore, no study data is available to report at this time.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1

Population: During transfer and acquisition of study record by sponsors, no study data has been located and all efforts to locate study data have been exhausted. Therefore, no study data is available to report at this time.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Day 1

Population: During transfer and acquisition of study record by sponsors, no study data has been located and all efforts to locate study data have been exhausted. Therefore, no study data is available to report at this time.

Outcome measures

Outcome data not reported

Adverse Events

Intranasal Application

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Extranasal Application

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Therapeutic Area, Head

Allergan

Phone: 714-246-4500

Results disclosure agreements

  • Principal investigator is a sponsor employee The investigator or other study-related personnel may not disclose to anyone or use any data, information, or materials related to this clinical trial without the express written consent of Oculeve.
  • Publication restrictions are in place

Restriction type: OTHER